Egyptian (CASE/EGX) Pharma Industry Analysis

UpdatedMar 02, 2026

DataAggregated Company Financials

Companies11

7D-1.5%
3M7.3%
1Y78.6%
YTD2.2%

Over the last 7 days, the Pharma industry has dropped 1.5%, driven by a pullback from Egyptian International Pharmaceutical Industries of 3.8%. In contrast, Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) (S.A.E) has gained 11%. In the past year, the industry has gained 79%. Earnings are forecast to grow by 25% annually.

Industry Valuation and Performance

Has the Egyptian Pharma Industry valuation changed over the past few years?

Date	Market Cap	Revenue	Earnings	PE	Absolute PE	PS
Mon, 02 Mar 2026	ج.م52.6b	ج.م35.1b	ج.م3.9b	12.7x	13.5x	1.5x
Wed, 28 Jan 2026	ج.م49.3b	ج.م35.1b	ج.م3.9b	13.6x	12.5x	1.4x
Fri, 26 Dec 2025	ج.م50.7b	ج.م34.7b	ج.م3.8b	16x	13.3x	1.5x
Sun, 23 Nov 2025	ج.م48.7b	ج.م33.6b	ج.م3.6b	16.1x	13.4x	1.5x
Tue, 21 Oct 2025	ج.م51.1b	ج.م33.0b	ج.م3.7b	15.1x	13.8x	1.6x
Thu, 18 Sep 2025	ج.م41.4b	ج.م31.8b	ج.م3.6b	13.8x	11.6x	1.3x
Sat, 16 Aug 2025	ج.م36.5b	ج.م31.1b	ج.م3.4b	10.8x	10.9x	1.2x
Mon, 14 Jul 2025	ج.م31.5b	ج.م29.4b	ج.م3.1b	8.8x	10.3x	1.1x
Wed, 11 Jun 2025	ج.م29.9b	ج.م28.1b	ج.م2.8b	6.9x	10.8x	1.1x
Fri, 09 May 2025	ج.م29.4b	ج.م26.2b	ج.م2.8b	8.1x	10.5x	1.1x
Sun, 06 Apr 2025	ج.م28.4b	ج.م26.2b	ج.م2.8b	7.9x	10.1x	1.1x
Tue, 04 Mar 2025	ج.م26.6b	ج.م24.8b	ج.م2.7b	6.9x	9.9x	1.1x
Thu, 30 Jan 2025	ج.م25.1b	ج.م23.8b	ج.م2.4b	9.1x	10.5x	1.1x
Sat, 28 Dec 2024	ج.م23.0b	ج.م23.7b	ج.م2.4b	8.6x	9.7x	1x
Mon, 25 Nov 2024	ج.م23.1b	ج.م23.2b	ج.م2.3b	6.8x	9.8x	1x
Wed, 23 Oct 2024	ج.م24.8b	ج.م22.1b	ج.م2.1b	7.2x	11.5x	1.1x
Fri, 20 Sep 2024	ج.م20.8b	ج.م22.6b	ج.م2.2b	5.9x	9.3x	0.9x
Sun, 18 Aug 2024	ج.م18.5b	ج.م22.0b	ج.م2.4b	5.2x	7.7x	0.8x
Tue, 16 Jul 2024	ج.م18.8b	ج.م21.3b	ج.م2.5b	5x	7.7x	0.9x
Thu, 13 Jun 2024	ج.م18.0b	ج.م21.1b	ج.م2.4b	5.9x	7.5x	0.9x
Sat, 11 May 2024	ج.م18.2b	ج.م19.8b	ج.م1.9b	7.8x	9.8x	0.9x
Mon, 08 Apr 2024	ج.م21.0b	ج.م19.4b	ج.م2.3b	7.9x	9.3x	1.1x
Wed, 06 Mar 2024	ج.م23.5b	ج.م18.5b	ج.م2.4b	9.7x	9.8x	1.3x
Fri, 02 Feb 2024	ج.م20.2b	ج.م18.5b	ج.م2.4b	8.1x	8.5x	1.1x
Sun, 31 Dec 2023	ج.م18.2b	ج.م15.3b	ج.م2.1b	6.5x	8.8x	1.2x
Tue, 28 Nov 2023	ج.م19.2b	ج.م16.3b	ج.م2.2b	9.5x	8.9x	1.2x
Thu, 26 Oct 2023	ج.م15.1b	ج.م15.4b	ج.م1.9b	6.2x	7.8x	1x
Sat, 23 Sep 2023	ج.م14.4b	ج.م15.9b	ج.م2.0b	7.1x	7.1x	0.9x
Mon, 21 Aug 2023	ج.م13.7b	ج.م15.7b	ج.م2.1b	7.6x	6.5x	0.9x
Wed, 19 Jul 2023	ج.م13.6b	ج.م15.6b	ج.م2.1b	7x	6.4x	0.9x
Fri, 16 Jun 2023	ج.م13.9b	ج.م16.2b	ج.م2.2b	5.4x	6.3x	0.9x
Sun, 14 May 2023	ج.م13.3b	ج.م16.2b	ج.م2.4b	4.1x	5.5x	0.8x
Tue, 11 Apr 2023	ج.م14.7b	ج.م16.2b	ج.م2.4b	5.2x	6.1x	0.9x
Thu, 09 Mar 2023	ج.م14.1b	ج.م15.7b	ج.م2.3b	5.3x	6.1x	0.9x

Price to Earnings Ratio

6.1x

Thu, 09 Mar 2023

Current Industry PE

Investors are optimistic on the Egyptian Pharmaceuticals industry, and appear confident in long term growth rates.

The industry is trading at a PE ratio of 13.5x which is higher than its 3-year average PE of 9.5x.

The 3-year average PS ratio of 1.1x is lower than the industry's current PS ratio of 1.5x.

Past Earnings Growth

The earnings for companies in the Pharmaceuticals industry have grown 19% per year over the last three years.
Revenues for these companies have grown 31% per year.
This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.